| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5825446 | Clinical Therapeutics | 2013 | 10 Pages |
Abstract
The results suggest that early initiation of combination therapy with 5-ARI + an AB, compared with delayed initiation, can reduce the risks for clinical progression, AUR, and prostate-related surgeries, as well as BPH-related medical costs, in patients with BPH.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Robert PhD, Bridgett PhD, Gabriel MS, Michael PharmD,